Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Rule 38.5 - Pfizer INC

4th Nov 2015 11:31

RNS Number : 5260E
Morgan Stanley & Co. Int'l plc
04 November 2015
 

 

 FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

 

1. KEY INFORMATION

 Name of exempt market-maker

Morgan Stanley & Co. International plc

 Company dealt in

PFIZER INC

 Class of relevant security to which the dealings being disclosed relate (Note 1)

US$0.05 COMMON STOCK

 Date of dealing

03 NOVEMBER 2015

 

 

2. DEALINGS (Note 2)

 

(a) Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  108,081

 35.0000 USD

 34.7166 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  108,081

 35.0000 USD

 34.7166 USD

 

 

(b) Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

(Note 4)

 Number of relevant securities

(Note 5)

 Price per unit

 CFD

 LONG

 1,200

 34.6958 USD

 CFD

 LONG

 1,300

 34.7100 USD

 CFD

 LONG

 358

 34.9227 USD

 CFD

 LONG

 498

 34.9419 USD

 CFD

 SHORT

 973

 34.6975 USD

 CFD

 SHORT

 1,141

 34.7163 USD

 CFD

 SHORT

 240

 34.8200 USD

 CFD

 SHORT

 774

 34.8271 USD

 CFD

 SHORT

 392

 34.8500 USD

 CFD

 SHORT

 1,000

 34.8875 USD

 CFD

 SHORT

 1,000

 34.9400 USD

 CFD

 SHORT

 400

 34.9400 USD

 CFD

 SHORT

 200

 34.9400 USD

 CFD

 SHORT

 200

 34.9550 USD

 CFD

 SHORT

 352

 34.9700 USD

 CFD

 SHORT

 3,436

 34.9769 USD

 

 

(c) Options transactions in respect of existing relevant securities

 

i) Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 N/A

 N/A

 N/A

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

04 NOVEMBER 2015

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ALLERGAN PLC

Nature of connection (Note 6)

Advisory

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEPKQDBDBDDODK

Related Shares:

PFZ.L
FTSE 100 Latest
Value8,680.29
Change47.96